Literature DB >> 1998507

A sensitive enzyme immunoassay for human basic fibroblast growth factor.

H Watanabe1, A Hori, M Seno, Y Kozai, K Igarashi, Y Ichimori, K Kondo.   

Abstract

A sensitive sandwich enzyme immunoassay for human basic fibroblast growth factor (HbFGF) was developed employing three monoclonal antibodies (MAb3H3, MAb98 and MAb52). The Fab' fragment of MAb3H3 which inhibits HbFGF biological activity was conjugated to horseradish peroxidase. A mixture of MAb52 and MAb98 was used in the solid phase. Neither human acidic fibroblast growth factor, hst-1/KS3 product nor acid denatured HbFGF was cross-reactive in this assay system. The detection limit of this assay system was 1 pg/well. Using this assay, some tumor cell lines were revealed to produce a higher level of bFGF than a normal one. Serum samples from normal volunteers were also assayed, and immuno-reactive HbFGF could be detected in 16 out of 57 samples at range 30 approximately 206 pg/ml.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998507     DOI: 10.1016/s0006-291x(05)81224-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Growth factors and renal cancer: characterization and therapeutic implications.

Authors:  J H Mydlo
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 2.  Angiogenic factors as tumor markers.

Authors:  M Nguyen
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

3.  Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease.

Authors:  K Jin-no; M Tanimizu; I Hyodo; F Kurimoto; T Yamashita
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

4.  Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.

Authors:  S Song; M G Wientjes; Y Gan; J L Au
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.

Authors:  M A Hull; J L Brough; D G Powe; G I Carter; D Jenkins; C J Hawkey
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

6.  Increase of basic fibroblast growth factor immunoreactivity and its mRNA level in rat brain following transient forebrain ischemia.

Authors:  K Takami; M Iwane; Y Kiyota; M Miyamoto; R Tsukuda; S Shiosaka
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 7.  Molecular and genetic prognostic factors of prostate cancer.

Authors:  Arnab Chakravarti; Gary Guotang Zhai
Journal:  World J Urol       Date:  2003-08-09       Impact factor: 4.226

8.  Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells.

Authors:  M Yamaguchi; S Diamond; H Watanabe; H Gallati; W Baur; J B Sharefkin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

9.  Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Authors:  D T Shima; A P Adamis; N Ferrara; K T Yeo; T K Yeo; R Allende; J Folkman; P A D'Amore
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

10.  Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.

Authors:  M A Hull; D J Cullen; N Hudson; C J Hawkey
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.